Medicamentos OTC, Genéricos y de Marca - FARMACIA DEL NIÑO

2550 products

SEROQUEL XR (QUETIAPINE) 25 MG 30 TABLETS

~~$ 1,450.00~~ $ 1,283.97

VAGITROL-V 10 OVULES

~~$ 723.00~~ $ 578.40

MYSOLINE (PRIMIDONE) 250 MG 50 TABLETS

$ 742.41

KALIOLITE (POTASSIUM CHLORIDE) 500 MG 50 COATED TABLETS

~~$ 383.24~~ $ 374.61

RELPAX (ELETRIPTAN) 80 MG 2 TAB

~~$ 890.93~~ $ 870.88

RELPAX (ELETRIPTAN) 40 MG 2 TAB

~~$ 651.30~~ $ 608.97

PREMARIN VAGINAL CREAM 43 G

~~$ 1,248.51~~ $ 1,162.98

PREMARIN Vaginal Cream 43 g

Comparable to: Premarin
Active ingredient: Conjugated estrogens
Presentation: Tube with 43 g of vaginal cream
Laboratory: Wyeth
Origin: Mexico

This medication is used for the treatment of vaginal symptoms associated with menopause, such as dryness, itching, and pain during sexual intercourse. Conjugated estrogens help restore the vaginal mucosa and improve tissue lubrication and elasticity.

The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.

THERAPEUTIC INDICATIONS: * Premarin vaginal cream is indicated for the treatment of vulvar atrophy, vaginal and vulvar kraurosis.

Contraindications: Suspected or confirmed pregnancy (see Restrictions of use during pregnancy and lactation).

Undiagnosed abnormal bleeding.

Suspected or confirmed estrogen-dependent neoplasia (eg endometrial cancer, endometrial hyperplasia).

History of active arterial thromboembolic disease (eg stroke, myocardial infarction) or deep thromboembolism (such as deep vein thrombosis, pulmonary embolism).

Dysfunction or active liver disease or chronic.

Known or suspected hypersensitivity to ingredients.

GENERAL PRECAUTIONS: Systemic absorption can occur with the use of vaginal cream with ECE. It must take into account the precautions and warnings associated with the oral treatment of ECE.

Fluid retention: Since estrogen / progestin may cause a degree of fluid retention in patients with conditions that can be influenced by this factor, such as cardiac or renal dysfunction, ensure careful observation when estrogens are prescribed.

In the study of health and osteoporosis, progestin and estrogen (HOPE), the mean increases from baseline in serum triglycerides after one year of treatment with CEE 0.625, 0.45 and 0.3 mg compared with placebo were 34.3,30.2 , 25.1, and 10.7 respectively.

Impaired liver function: Patients with impaired liver function may metabolize poorly estrogen / progestin.

History of cholestatic jaundice: For patients with a history of cholestatic jaundice associated with past use of estrogen or pregnancy, caution should be exercised, and in case of recurrence, medication should be discontinued.

DOSAGE AND ADMINISTRATION: The Administration should be cyclic (eg, three weeks of application and one week off) and only for short periods.

You must select the lowest dose that controls your symptoms and should be discontinued ifsymptoms persist.

Usual dose range: ½ to two grams a day, vaginally, depending on the severity of the condition. Ensure that the discontinuation or reduction of medication takes place at intervals of 3 to 6 months.

Concomitant progestogen: The addition of a progestin during the administration of estrogenreduces the risk of endometrial hyperplasia and carcinoma, which has been associated withlong-term use of unopposed estrogen.

Morphological and biochemical studies of endometrium suggest that you need to manage for 10 to 14 days to provide maximum maturation of the endometrium in order to eliminate anyhyperplastic alteration.

Since progestogens are administered to protect against endometrial hyperplastic changes, patients without a uterus may not need a progestin. Administration should be cyclic (eg, three weeks of treatment and rest) and only for short-term therapy.

Patients should be reevaluated periodically to determine whether treatment of the symptomsis still necessary.

PROVERA (MEDROXYPROGESTERONE) 5 MG 24 TAB

~~$ 587.21~~ $ 573.99

PROGYLUTON (ESTRADIOL-NORGESTREL) 21 DRAGEES

~~$ 944.00~~ $ 802.40

PREMARIN 0.625 MG 42 TABLETS

~~$ 1,504.86~~ $ 1,401.78

BACTRIM F (SULFAMETHOXAZOLE / TRIMETHOPRIM) 160 MG / 800 MG 15 TAB

~~$ 590.00~~ $ 472.00

BACTRIM F (SULFAMETHOXAZOLE / TRIMETHOPRIM) 160 mg / 800 mg

Comparable to: Bactrim F
Active ingredient: Sulfamethoxazole / Trimethoprim
Concentration: 160 mg / 800 mg per tablet
Presentation: Box with 15 tablets
Laboratory: Waserpharma, S. A. DE CV
Origin: Mexico

This medication is used for the treatment of various bacterial infections, such as urinary tract, respiratory, gastrointestinal infections, and others caused by susceptible microorganisms. The combination of sulfamethoxazole and trimethoprim works by inhibiting folate synthesis in bacteria, which prevents their growth and reproduction.

The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.

Prescription required for sale.

THERAPEUTIC INDICATIONS:

Acute otitis media: Co-trimoxazole is used in children and adults for the treatment of acute otitis media (AOM) caused by susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when the clinician makes the trial that the drug offers some use of surplus the advantage of a single anti-infective. Limited data to date regarding safety of repeated use of co-trimoxazole in pediatric patients under 2 years of age, the drug should not be administered prophylactically or for long periods for treatment of otitis media in any age group .

Several antibiotics, including oral amoxicillin, amoxicillin and clavulanate potassium oral different oral cephalosporins (cefaclor, cefdinir, cefixime, cefpodoxil proxetil, cefprozil, ceftibuten, acetyl cefuroxime, cephalexin), IM ceftriaxone, oral co-trimoxazole, erythromycin-sulfisoxazole oral , oral azithromycin, clarithromycin, oral, and oral loracarbef, have been used in the treatment of the AAP, CDC, and other clinicians suggest that, despite the increasing prevalence of S. Multidrug-resistant pneumoniae and Haemophilus influenzae the presence of ß-lactamase producer or M. catarrhalis in many communities, amoxicillin remains the first choice anti-infective for treatment of AOM straightforward because amoxicillin is highly effective, has a narrow spectrum of activity, is well distributed in the middle ear fluid, and is well tolerated. Co-trimoxazole is not considered a first line agent for the treatment of AOM, but is recommended as an alternative for individuals with some type of hypersensitivity to penicillin, because S. pneumoniae resistant to amoxicillin are also often resistant to co-trimoxazole, clarithromycin, and azithromycin
CONTRAINDICATIONS: BACTIVER * is contraindicated in severe hepatic parenchymal disease, blood dyscrasias and severe renal insufficiency, when there is no identifiable plasma regularly.

BACTIVER * not be administered to patients with a history of hypersensitivity to sulfonamides or trimethoprim.Do not administer during pregnancy and lactation, even in preterm infants and infants under 3 months old.

BACTIVER * not be administered to patients with serious blood disorders. Has been given co-trimoxazole in patients undergoing cytotoxic therapy with little or no additional effect on bone marrow or peripheral blood.

BACTIVER * not be given to premature or term infants during the neonatal period.

CAUTIONS: BACTIVER * should be used with caution in patients with impaired renal or liver function, or those with folate deficiency (elderly chronic alcoholics, patients receiving anticonvulsant therapy, patients with intestinal malabsorption and poor nutritional status) and all with allergy and asthma problems.

In patients with glucose-6-phosphate dehydrogenase hemolysis may occur. In elderly patients, may increase the possibility of adverse reactions, particularly when there are complications such as renal function impairment or hepatic impairment.

BACTIVER * not be used for periods longer than 15 days without strict medical supervision.

DOSAGE AND ADMINISTRATION:

Standard Dose: The standard dose for adults and children over 12 years are listed below:

Standard dose for adults and children over 12 years:

  Forte tablets

morning
  night

standard dose
  1
  1

Minimum dose and dose therapy

long term (more than 14 days)
  ½
  ½

High dose (particularly for cases

serious mind)
  1 ½
  1 ½

The best way to take BACTIVER ® F is after meals, with an adequate amount of fluids.

Duration of treatment: acute, BACTIVER ® F should be administered for at least 5 days or until the patient shows no symptoms for 2 days minimum. If no clinical improvement is evident after 7 days of therapy, the patient should be reassessed.